Mimedx

Board of Directors

1. Parker H. "Pete" Petit | Chairman

   1. Mr. Petit was Chairman and CEO of Matria Healthcare which was sold to Inverness Medical Innovations in May of 2008. Matria Healthcare was a former subsidiary of Healthdyne, which Mr. Petit founded in 1970. Mr. Petit served as Chairman and CEO of Healthdyne and several of its publicly traded subsidiaries after Healthdyne became a publicly traded company in 1981. One of Healthdyne's other subsidiaries was merged with Respironics in 1995, and Respironics was sold in 2008 to Phillips Healthcare.

      Mr. Petit received his Bachelor's degree in Mechanical Engineering and Master of Science degree in Engineering Mechanics from Georgia Institute of Technology and an MBA degree in Finance from Georgia State University. At Georgia Tech, Mr. Petit funded a professorial chair for "Engineering in Medicine", endowed the Petit Institute for Bioengineering and Bioscience, and assisted with the funding of the Biotechnology Building which bears his name. At Georgia State University, he assisted with the funding of the Science Center building which also bears his name. In 1994, he was inducted into the Technology Hall of Fame of Georgia. In 2007, he was inducted into the Georgia State Business School Hall of Fame. Mr. Petit has previously served as a member of the Board of Directors of the Georgia Research Alliance which is chartered by the State of Georgia to promote high technology and scientific development in the State. He has also previously served on several public company Boards of Directors.

2. Joseph G. Bleser

   1. Mr. Bleser became a financial consultant serving public and private companies in the healthcare and technology industries in 1998 after serving for over 20 years as Chief Financial Officer for several public companies in the healthcare and technology industries, including HBO & Company, Allegiant Physician Services, and Transcend Services, and Healthcare.com, a Matria Healthcare public subsidiary. Mr. Bleser is a member of the Board of Directors, the Audit Committee and the Corporate Governance Committee of Transcend Services [NASDAQ: TRCR]. In addition, Mr. Bleser serves on the Board of Directors of a privately held information technology solutions company. Mr. Bleser is a licensed Certified Public Accountant with ten prior years of public accounting experience in an international public accounting firm.

3. J. Terry Dewberry

   1. Mr. J. Terry Dewberry, is a private investor with extensive experience at both the management and board levels in the healthcare industry. He most recently served as a Director with Respironics, Inc. and Matria Healthcare, Inc. where he served as a member of various committees including the Audit and Compensation committees. In 2008 both Respironics and Matria Healthcare were sold to larger companies. He currently serves on the board of DrTango, Inc., a private company in the multicultural communications and health management industry. He served as a Director, Vice Chairman, President and Chief Operating Officer, Executive Vice President and Chief Financial Officer of Healthdyne, Inc from 1981 to 1996. He has extensive experience in corporate mergers and takeovers on both the buy and sell sides at sizes up to $5 billion.

4. Kurt M. Eichler

   1. Mr. Eichler is employed by LCOR Incorporated, a multi-billion dollar real estate investment and development company, where he has worked since 1981. He is currently serving as Principal and Executive Vice President in charge of operations of the metropolitan New York region. Based in New York City, Mr. Eichler also serves on LCOR's Executive Committee. Currently, Mr. Eichler is an investor in several biotech companies and serves as a Director of DARA BioSciences, Inc, a publicly-traded company [NasdaqCM: DARA].

5. Steven Gorlin

   1. Steve Gorlin, Director, is a founder of the company. Over the past 35 years, Mr. Gorlin has founded several biotechnology and pharmaceutical companies, including Hycor Biomedical, Inc., Theragenics Corporation, CytRx Corporation, Medicis Pharmaceutical Corporation, EntreMed, Inc., Surgi-Vision, Inc., DARA BioSciences, Inc. [Nasdaq:DARA], SpineMedica Corp., and Medivation, Inc. [Nasdaq: MDVN]. Mr. Gorlin also currently serves on the Board of Directors of the following private companies: Nano Technology Corporation (China), and Surgi-Vision, Inc.

6. Bruce L. Hack

   1. Mr. Hack was Vice Chairman of the Board and Chief Corporate Officer of Activision Blizzard until 2009. Prior to that, Mr. Hack was Chief Executive Officer of Vivendi Games, from 2004 to 2008, Vice Chairman of the Board, Universal Music Group, from 1998 to 2001, and Chief Financial Officer, Universal Studios, from 1995 to 1998. From 1982-1994, Mr. Hack held several positions at The Seagram Company, including: Assistant to the Executive Vice President, Sales and Marketing, for Seagram USA; Director, Strategic Planning, at The Seagram Company Ltd.; and Chief Financial Officer of Tropicana Products, Inc. Prior thereto, he was a trade negotiator for the U.S. Treasury. He has been Director of iSuppli Corporation since September 2007. Mr. Hack earned a B.A. in government at Cornell University and an M.B.A. in finance at the University of Chicago.

7. Charles E. Koob

   1. Mr. Koob joined the law firm of Simpson Thacher & Bartlett, LLP in 1970 and became a partner in 1977. He retired from that firm on January 1, 2007 but remains of counsel. While at that firm, Mr. Koob was the co-head of the Litigation Department and served on the Firm's Executive Committee. Mr. Koob specializes in competition, trade regulation and antitrust issues. Throughout his 37-year tenure, he has represented clients before the Federal Trade Commission, the Antitrust Division of the Department of Justice, and numerous state and foreign competition authorities. His resume includes the representation of Virgin Atlantic Airways, Archer Daniels Midland, and Kohlberg Kravis Roberts and Co. He received his B.A. from Rockhurst College in 1966 and his J.D. from Stanford Law School in 1969. In addition to his practice, Mr. Koob is trustee of the Natural Resources Defense Council, is President of the Yellowstone Park Foundation and is the co-chair of the Steering Committee for the current campaign for Stanford Law School. Mr. Koob is the brother of Dr. Thomas J. Koob, Chief Scientific Officer of MiMedx Group.

8. Larry W. Papasan

   1. From July 1991 until his retirement in May 2002, Mr. Papasan served as President of Smith & Nephew Orthopaedics. He has been a Director and Chairman of the Board of Directors of BioMimetic Therapeutics [NasdaqGM:BMTI] since August 2005. BioMimetic Therapeutics, Inc. is developing and commercializing bio-active recombinant protein-device combination products for the healing of musculoskeletal injuries and disease, including orthopedic, periodontal, spine and sports injury applications. Mr. Papasan has also served as a member of the Board of Directors of Reaves Utility Income Fund [NasdaqCM:UTG], a closed-end management investment company, since February 2003 and of Triumph Bankshares, Inc. (a bank holding company) since April 2005. Mr. Papasan also serves as a Director of SSR Engineering, Inc. and AxioMed Spine Corporation.

9. Andrew K. Rooke, Jr.

   1. Mr. Andrew K. "Kreamer" Rooke, Jr. has been involved with MiMedx Group since inception. Mr. Rooke was one of the initial investors in the Company and he worked directly with Steven Gorlin from January 2007 to June 2008, during which time he advised on the acquisition of SpineMedica and aided in the Company's emergence into the public market. During this time, he also worked with the Gorlin Companies, assisting in the management and capitalization of a group of portfolio companies and new investment opportunities. Currently, Mr. Rooke is handling his family's private investments and company's affairs. From 2003 to 2006, Mr. Rooke studied at the University of Pennsylvania, where he received a Bachelor's degree in Economics.

10. William C. Taylor

    1. Mr. Taylor is an operating executive with over 20 years experience in healthcare product design, development and manufacturing. From 2001 through 2006, Mr. Taylor was President of Facet Technologies, LLC, a Matria Healthcare subsidiary. Facet was a medical device company focused on medical device design, development, and manufacturing for OEM clients such as Abbott, Bayer, BD, LifeScan (J&J), Roche, and Flextronics. Over his 14 year career at Facet and its predecessor company, he held various management positions, beginning with R&D, QA & Regulatory Affairs and progressing through General Management. Mr. Taylor was instrumental in growing the design and manufacturing business from $14 million in revenue up to over $40 million, when the company was sold to Matria Healthcare. As President, he led the company to the number one market position in Microsampling and grew it to over $85 million in revenue. He also led the company as CEO for 18 months after it was sold to a private equity company. A graduate of Purdue University, Mr. Taylor holds a Bachelor of Science degree in Mechanical Engineering and is co-inventor on eight patents. Mr. Taylor also serves on the Board of Directors